查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1386254

女性健康疾病診斷與治療市場報告：到2030年的趨勢、預測與競爭分析

Women Health Disease Diagnosis & Treatment Market Report: Trends, Forecast and Competitive Analysis to 2030
出版日期: | 出版商: Lucintel | 英文 150 Pages | 商品交期: 3個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

女性健康疾病診治趨勢及預測

預計到2030年，全球女性健康疾病診斷與治療市場預計將達到281.9億美元，2024年至2030年年複合成長率為6.5%。該市場的主要促進因素是女性健康疾病發病率的上升、女性醫療保健意識的提高以及擴大採用現場護理和快速診斷測試。全球女性健康疾病診斷與治療市場前景廣闊，醫院、診所和診斷中心市場充滿商機。

女性健康疾病診治市場洞察

Lucintel 預測，癌症預計將在預測期內經歷最高的成長。

醫院仍然是該市場中最大的部分。

由於該地區醫療基礎設施的不斷改善、對婦女健康疾病的認知不斷提高以及 POC 診斷的採用率不斷提高，預計亞太地區將在預測期內實現最高的成長。

本報告回答了 11 個關鍵問題：

  • Q.1. 細分市場中最有前途和高成長的機會是什麼？
  • Q.2.哪個細分市場將以更快的速度成長？為什麼？
  • Q.3.您認為哪些地區未來會出現更快的成長？為什麼？
  • Q.4. 影響市場動態的主要因素有哪些？市場的主要挑戰和商業風險是什麼？
  • Q.5. 這個市場的商業風險和競爭威脅是什麼？
  • Q.6.這個市場有哪些新趨勢？為什麼？
  • Q.7.市場客戶需求有何改變？
  • Q.8. 該市場有哪些新發展以及哪些公司處於領先地位？
  • Q.9.這個市場的主要企業有哪些？主要企業採取哪些策略配合措施來發展業務？
  • Q.10. 該市場上的競爭產品有哪些？由於材料或產品替代而導致市場佔有率下降的威脅有多大？
  • Q.11.過去年度發生了哪些併購事件，對產業產生了哪些影響？

目錄

第1章 執行摘要

第2章 全球女性健康疾病診療市場：市場動態

  • 簡介、背景、分類
  • 供應鏈
  • 產業促進因素與挑戰

第3章 2018-2030年市場趨勢及預測分析

  • 宏觀經濟趨勢（2018-2023）與預測（2024-2030）
  • 全球女性健康疾病診斷與治療市場趨勢（2018-2023）與預測（2024-2030）
  • 按類型分類的全球女性健康疾病診斷與治療市場
    • 尿道感染及其病症
    • 產前生殖健康
    • 閉經
    • 癌症
    • 骨質疏鬆症
  • 全球女性健康疾病診斷與治療市場（按最終用途）
    • 醫院
    • 診所
    • 診斷中心
    • 其他

第4章 2018-2030年分地區市場趨勢及預測分析

  • 全球女性健康疾病診斷與治療市場區域分佈
  • 北美女性健康疾病診療市場
  • 歐洲女性健康疾病診治市場
  • 亞太女性健康疾病診斷與治療市場
  • 其他地區女性健康疾病診療市場

第5章 競爭分析

  • 產品系列分析
  • 營運整合
  • 波特五力分析

第6章 成長機會與策略分析

  • 成長機會分析
    • 全球女性健康疾病診斷與治療市場成長機會（按類型）
    • 全球女性健康疾病診斷與治療市場成長機會（以最終用途）
    • 全球女性健康疾病診斷與治療市場按地區成長機會
  • 全球女性健康疾病診療市場新趨勢
  • 戰略分析
    • 新產品開發
    • 擴大全球女性健康診斷和治療市場的能力
    • 全球女性健康診斷和治療市場的合併和收購
    • 認證和許可

第7章 主要企業概況

  • General Electric
  • CooperSurgical
  • ASCEND Therapeutics
  • Rinovum Women's Health
  • Quest Diagnostics Incorporated
  • Hologic
  • PerkinElmer
  • Cardinal Health
  • Becton and Dickinson
  • Abbott Laboratories
簡介目錄

Women Health Disease Diagnosis & Treatment Trends and Forecast

The future of the global women health disease diagnosis & treatment market looks promising with opportunities in the hospital, clinic, and diagnostic center markets. The global women health disease diagnosis & treatment market is expected to reach an estimated $28.19 billion by 2030 with a CAGR of 6.5% from 2024 to 2030. The major drivers for this market are risng number of women health disorders, growing awareness concerning women healthcare, and increasing adoption of point-of-care and rapid diagnostic tests.

A more than 150-page report is developed to help in your business decisions.

Women Health Disease Diagnosis & Treatment by Segment

The study includes a forecast for the global women health disease diagnosis & treatment by type, end use, and region.

Women Health Disease Diagnosis & Treatment Market by Type [Shipment Analysis by Value from 2018 to 2030]:

  • Urinary Tract Infection and Condition
  • Prenatal Reproductive Health
  • Menopause
  • Cancer
  • Osteoporosis

Women Health Disease Diagnosis & Treatment Market by End Use [Shipment Analysis by Value from 2018 to 2030]:

  • Hospitals
  • Clinics
  • Diagnostic Centers
  • Others

Women Health Disease Diagnosis & Treatment Market by Region [Shipment Analysis by Value from 2018 to 2030]:

  • North America
  • Europe
  • Asia Pacific
  • The Rest of the World

List of Women Health Disease Diagnosis & Treatment Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies women health disease diagnosis & treatment companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the women health disease diagnosis & treatment companies profiled in this report include-

  • General Electric
  • Coopersurgical
  • Ascend Therapeutics
  • Rinovum Women'S Health
  • Quest Diagnostics Incorporated
  • Hologic
  • Perkinelmer
  • Cardinal Health
  • Becton and Dickinson
  • Abbott Laboratories

Women Health Disease Diagnosis & Treatment Market Insights

Lucintel forecasts that cancer is expected to witness highest growth over the forecast period.

Within this market, hospitals will remain the largest segment.

APAC is expected to witness highest growth over the forecast period due to on-going improvement of healthcare infrastructure, growing awareness towards women's health disorders, and rising adoption of POC diagnostics in the region.

Features of the Global Women Health Disease Diagnosis & Treatment Market

Market Size Estimates: Women Health Disease Diagnosis & Treatment Market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Women Health Disease Diagnosis & Treatment Market size by type, end use, and region in terms of value ($B).

Regional Analysis: Women Health Disease Diagnosis & Treatment Market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different types, end uses, and regions for the women health disease diagnosis & treatment market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the women health disease diagnosis & treatment market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q.1 What is the women health disease diagnosis & treatment market size?

Answer: The global women health disease diagnosis & treatment market is expected to reach an estimated $28.19 billion by 2030.

Q.2 What is the growth forecast for women health disease diagnosis & treatment market?

Answer: The global women health disease diagnosis & treatment market is expected to grow with a cagr of 6.5% from 2024 to 2030.

Q.3 What are the major drivers influencing the growth of the women health disease diagnosis & treatment market?

Answer: The major drivers for this market are risng number of women health disorders, growing awareness concerning women healthcare, and increasing adoption of point-of-care and rapid diagnostic tests.

Q4. What are the major segments for women health disease diagnosis & treatment market?

Answer: The future of the women health disease diagnosis & treatment market looks promising with opportunities in the hospital, clinic, and diagnostic center markets.

Q5. Who are the key women health disease diagnosis & treatment market companies?

Answer: Some of the key women health disease diagnosis & treatment companies are as follows:

  • General Electric
  • CooperSurgical
  • ASCEND Therapeutics
  • Rinovum Women's Health
  • Quest Diagnostics Incorporated
  • Hologic
  • PerkinElmer
  • Cardinal Health
  • Becton and Dickinson
  • Abbott Laboratories

Q6. Which women health disease diagnosis & treatment market segment will be the largest in future?

Answer: Lucintel forecasts that cancer is expected to witness highest growth over the forecast period.

Q7. In women health disease diagnosis & treatment market, which region is expected to be the largest in next 5 years?

Answer: APAC is expected to witness highest growth over the forecast period due to on-going improvement of healthcare infrastructure, growing awareness towards women's health disorders, and rising adoption of POC diagnostics in the region.

Q.8 Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

  • Q.1. What are some of the most promising, high-growth opportunities for the women health disease diagnosis & treatment market by type (urinary tract infection and condition, prenatal reproductive health, menopause, cancer, and osteoporosis), end use (hospitals, clinics, diagnostic centers, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
  • Q.2. Which segments will grow at a faster pace and why?
  • Q.3. Which region will grow at a faster pace and why?
  • Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
  • Q.5. What are the business risks and competitive threats in this market?
  • Q.6. What are the emerging trends in this market and the reasons behind them?
  • Q.7. What are some of the changing demands of customers in the market?
  • Q.8. What are the new developments in the market? Which companies are leading these developments?
  • Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
  • Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
  • Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Women Health Disease Diagnosis & Treatment Market : Market Dynamics

  • 2.1: Introduction, Background, and Classifications
  • 2.2: Supply Chain
  • 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

  • 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
  • 3.2. Global Women Health Disease Diagnosis & Treatment Market Trends (2018-2023) and Forecast (2024-2030)
  • 3.3: Global Women Health Disease Diagnosis & Treatment Market by Type
    • 3.3.1: Urinary Tract Infection and Condition
    • 3.3.2: Prenatal Reproductive Health
    • 3.3.3: Menopause
    • 3.3.4: Cancer
    • 3.3.5: Osteoporosis
  • 3.4: Global Women Health Disease Diagnosis & Treatment Market by End Use
    • 3.4.1: Hospitals
    • 3.4.2: Clinics
    • 3.4.3: Diagnostic Centers
    • 3.4.4: Others

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

  • 4.1: Global Women Health Disease Diagnosis & Treatment Market by Region
  • 4.2: North American Women Health Disease Diagnosis & Treatment Market
    • 4.2.2: North American Women Health Disease Diagnosis & Treatment Market by End Use: Hospitals, Clinics, Diagnostic Centers, and Others
  • 4.3: European Women Health Disease Diagnosis & Treatment Market
    • 4.3.1: European Women Health Disease Diagnosis & Treatment Market by Type: Urinary Tract Infection and Condition, Prenatal Reproductive Health, Menopause, Cancer, and Osteoporosis
    • 4.3.2: European Women Health Disease Diagnosis & Treatment Market by End Use: Hospitals, Clinics, Diagnostic Centers, and Others
  • 4.4: APAC Women Health Disease Diagnosis & Treatment Market
    • 4.4.1: APAC Women Health Disease Diagnosis & Treatment Market by Type: Urinary Tract Infection and Condition, Prenatal Reproductive Health, Menopause, Cancer, and Osteoporosis
    • 4.4.2: APAC Women Health Disease Diagnosis & Treatment Market by End Use: Hospitals, Clinics, Diagnostic Centers, and Others
  • 4.5: ROW Women Health Disease Diagnosis & Treatment Market
    • 4.5.1: ROW Women Health Disease Diagnosis & Treatment Market by Type: Urinary Tract Infection and Condition, Prenatal Reproductive Health, Menopause, Cancer, and Osteoporosis
    • 4.5.2: ROW Women Health Disease Diagnosis & Treatment Market by End Use: Hospitals, Clinics, Diagnostic Centers, and Others

5. Competitor Analysis

  • 5.1: Product Portfolio Analysis
  • 5.2: Operational Integration
  • 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

  • 6.1: Growth Opportunity Analysis
    • 6.1.1: Growth Opportunities for the Global Women Health Disease Diagnosis & Treatment Market by Type
    • 6.1.2: Growth Opportunities for the Global Women Health Disease Diagnosis & Treatment Market by End Use
    • 6.1.3: Growth Opportunities for the Global Women Health Disease Diagnosis & Treatment Market by Region
  • 6.2: Emerging Trends in the Global Women Health Disease Diagnosis & Treatment Market
  • 6.3: Strategic Analysis
    • 6.3.1: New Product Development
    • 6.3.2: Capacity Expansion of the Global Women Health Disease Diagnosis & Treatment Market
    • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Women Health Disease Diagnosis & Treatment Market
    • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

  • 7.1: General Electric
  • 7.2: CooperSurgical
  • 7.3: ASCEND Therapeutics
  • 7.4: Rinovum Women's Health
  • 7.5: Quest Diagnostics Incorporated
  • 7.6: Hologic
  • 7.7: PerkinElmer
  • 7.8: Cardinal Health
  • 7.9: Becton and Dickinson
  • 7.10: Abbott Laboratories